NCT03978130Completed
Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease
Source: ClinicalTrials.gov · Last updated 6 Jun 2025
Brief summary (registry, in English)
RESILIENT is a phase II, multi-center, prospective, pragmatic randomized clinical trial with blinded assessment of the primary endpoint. This study aims to evaluate whether mHealth-CR improves functional capacity in older adults (age ≥65) with IHD compared with standard traditional cardiac rehabilitation care. A total of 400 eligible patients will be randomized in 3:1 manner to mHealth-CR versus usual care for assessment of primary endpoint. Enrollment will occur over approximately 42 months with an expected minimum of 3 months follow-up per participant.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 400 (actual)
- First submitted
- 5 Jun 2019
- Start date
- 9 Jan 2020
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- NYU Langone Health
- Diseases
- Coronary artery disease
- NCT number
- NCT03978130
What you commit to
- Study type: Interventional
- Participants enrolled: 400
- From 9 Jan 2020 to the primary completion date, 30 Apr 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Completion of ambulatory cardiac rehabilitation program within prior 3 months.
Other illness
- Moderate or severe cognitive impairment.
- Parkinson's disease or other progressive movement disorder.
- Currently listed for heart transplant.
Other
- Non-ambulatory.
- Unable/unwilling to consent.
- PCI-related groin hematoma that precludes brisk walking.
- Incarcerated.
- Unable to use mHealth software in English or Spanish.
- Severe osteoarthritis, or joint replacement within last 3 months.
- Regular use of walker for ambulation.
- Projected life expectancy \<3 months.
- Clinical judgment concerning other safety or nonadherence issues.
- Participants admitted from long-term care facility.
- Left ventricular assist device recipient.
Who the study is looking for
- Age ≥65
- Currently hospitalized for AMI, PCI, or CABG or Hospitalized for AMI, PCI or CABG within prior 2 weeks.
- Capable of self-consent.
- Understand and are able to perform study procedures (i.e. 6-minute walk test, use mHealth in English or Spanish).
Age in the registry: 65 years to 110 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| UMass Chan Medical School Coordinator of this site? Confirm its status | Worcester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.